Megan Blewett
InvestorPrincipal at Scion Life Sciences
San Francisco Bay Area
Writes $10K β $100K checks Β· typically $50K
About
Megan Blewett joined Scion Life Sciences as a Principal on the investment team in 2025. She was previously an investor at Venrock, where she co-founded Kelonia Therapeutics (acquired by Eli Lilly) and Iris Medicine, later taking operating roles at both companies, including serving as President of Iris Medicine. She earned a PhD as a Hertz Fellow from the Scripps Research Institute and holds an AB/AM in chemistry from Harvard.
Invests in
Biotech
Experience
- Scion Life SciencesPrincipalcurrent2025 β presentNew York, New York, United States
- Hertz FoundationBoard Membercurrent2026 β present
- Convergent ResearchBoard Membercurrent2022 β present
- Iris MedicineCo-Founder and President2024 β 2025
- Iris MedicineCo-Founder and VP Corporate Development2022 β 2024
- Kelonia TherapeuticsCo-Founder and Director of Business Development2019 β 2021
- VenrockLife sciences investor2017 β 2020Palo Alto, CA
Education
- Harvard UniversityAB/AM, Chemistry2007 β 2011
- Scripps ResearchDoctor of Philosophy (Ph.D.), Chemistry2012 β 2016
Skills & more
Biochemistry12Mass Spectrometry11Bioinformatics5Molecular Biology10Organic Synthesis10Chemistry10Organic Chemistry8Proteomics5Metabolomics2Immunology7NMR6Biotechnology2
Languages French Β· Mandarin
From Megan's professional profile.
Same school
Also attended Harvard University1,173
Alfred LinPartner at Sequoia CapitalChris DixonFounder & Managing Partner of a16z crypto at Andreessen HorowitzSarah TavelVenture Partner at BenchmarkDanny RimerPartner at Index VenturesLaela SturdyManaging Partner at CapitalGRyan IsonoDeal Partner at Felicis Ventures
+ 1,167 more
Shared employers
Also worked at Hertz Foundation3
Also worked at Convergent Research3
Also worked at Kelonia Therapeutics1
Also worked at Venrock77
Yonatan SelaPartner at Square Peg CapitalMark BaileyFounder and Partner Emeritus at DFJPriya BanerjeeSenior Principal at B4 CapitalRyan GilbertFounder and Managing Partner at Launchpad CapitalSean O'MalleyPartner at Launchpad CapitalArif FarooquiVice President, Finance at Cota Capital
+ 71 more
Investments
Investor
Iris MedicineKelonia Therapeutics
Per the firm's website.
Colleagues at Scion Life Sciences
Aaron Kantoff
Managing Partner at Scion Life Sciences
Andreas Loew
Partner at Scion Life Sciences
Dave Katona
Head of Business Development & Investor Relations at Scion Life Sciences
Elliot Warner
Associate at Scion Life Sciences
Huw Nash
Venture Partner at Scion Life Sciences
Jeffrey Edelman
Partner at Scion Life Sciences
Lalo Flores
Venture Partner at Scion Life Sciences
Romesh Subramanian
Venture Partner at Scion Life Sciences
























